No Data
No Data
CCORF Maintains Generation Bio(GBIO.US) With Buy Rating, Maintains Target Price $9
Promising Pipeline and Strong Financials Affirm Buy Rating for Generation Bio
Generation Bio GAAP EPS of -$0.23, Revenue of $7.55M
Hold Rating Maintained for Generation Bio Amid Technological Progress and Timeline Uncertainty
TD Cowen Maintains Generation Bio(GBIO.US) With Hold Rating
Generation Bio: Hold Rating Due to Positive Developments and Uncertain IND Timelines
No Data
No Data